Jaren Madden
Investor Relations Contact at SCHRÖDINGER, INC.
Jaren Madden active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SCHRÖDINGER, INC. | Investor Relations Contact | 01/11/2020 | - |
| Public Communications Contact | 01/11/2020 | - |
Career history of Jaren Madden
Former positions of Jaren Madden
| Companies | Position | Start | End |
|---|---|---|---|
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Chief Tech/Sci/R&D Officer | 01/11/2017 | 01/07/2018 |
| INFINITY PHARMACEUTICALS, INC. | Investor Relations Contact | 01/01/2010 | 01/01/2017 |
| Public Communications Contact | 01/01/2010 | 01/01/2017 | |
| GAMIDA CELL LTD. | Investor Relations Contact | 01/07/2018 | - |
| Public Communications Contact | 01/07/2018 | - |
Training of Jaren Madden
| University of Connecticut | Graduate Degree |
| Boston University | Masters Business Admin |
Statistics
International
| United States | 5 |
| United Kingdom | 2 |
| Israel | 2 |
Operational
| Investor Relations Contact | 3 |
| Public Communications Contact | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| GAMIDA CELL LTD. | Health Technology |
| SCHRÖDINGER, INC. | Technology Services |
| Private companies | 1 |
|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
- Stock Market
- Insiders
- Jaren Madden
- Experience
